Therapeutic insights into restoring the contractility of heart muscle function during heart failure: Ginsenoside Rb₁ improves cardiac contractility and function via down regulation of its target gene, 27/April/2014, 5.46 am

Insight into the treatment of Metastatic Pancreatic/intestine/ovarian Cancer: C/EBPzeta (CHOP/Gadd153) suppresses the expression of PDGF Receptor β via up regulation of its target gene, 26/April/2014, 8.56 am
April 26, 2014
The arthritis drug Withaferin A (WFA) suppresses the expression of tumor suppressor RECK via up regulation of its target gene, 27/April/2014, 5.51 am
April 27, 2014
Show all

A study from University of California, San Diego, and Sanford-Burnham Medical Research Institute, La Jolla, California, USA shows that Inhibition of miR-25 improves cardiac contractility in the failing heart. This study was published in the April 24, 2014 Nature by Prof. Dr Mark Mercola and others from the Department of Bioengineering, University of California, San Diego, and the Muscle Development and Regeneration Program, Sanford-Burnham Medical Research Institute, La Jolla, California, USA.

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that:  Therapeutic insights into restoring the contractility of heart muscle function: Ginsenoside Rb₁ improves cardiac contractility and function via down regulation of its target gene.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Therapeutic insights into restoring the contractility of heart muscle function during heart failure: Ginsenoside Rb₁ improves cardiac contractility and function via down regulation of its target gene, 27/April/2014, 5.46 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.